We have updated our privacy policy and terms & conditions. Find out more here.
0
 

BEL Pharma and Bio-technology (BEPB)

Add to/Remove from a Portfolio  
2,040.92 -38.70    -1.86%
27/07 - Closed. Currency in EUR ( Disclaimer )
Type: Index
Market: Belgium
# Components: 8

  • Volume: -
  • Open: 2,080.39
  • Day's Range: 2,039.80 - 2,080.39
Start Trading
Pharma & Bio-tech 2,040.92 -38.70 -1.86%
Add to/Remove from a Portfolio  

Pharma & Bio-tech Overview

Prev. Close2,040.92
Volume-
Day's Range2,039.80 - 2,080.39
Open2,080.39
Average Vol. (3m)-
52 wk Range1630.66 - 2104.18
1-Year Return12.6%

BEL Pharma and Bio-technology News & Analysis

Related Articles

Most Active Stocks

  Name Last Prev. High Low Chg. % Vol. Time
Tigenix NV 0.8080 0.8080 0.8200 0.7800 -1.58% 798.32K 27/07  
Ablynx NV 13.500 13.500 14.080 13.005 -3.57% 395.08K 27/07  
Galapagos 49.880 49.880 51.600 49.510 -2.96% 251.56K 27/07  
UCB 69.50 69.50 70.36 69.39 -1.52% 215.26K 27/07  
Mdxhealth 4.799 4.799 4.890 4.760 -0.02% 142.67K 27/07  
Celyad 51.51 51.51 53.90 51.02 -4.51% 27.04K 27/07  
Thrombogenics 5.270 5.270 5.420 5.270 -3.66% 25.62K 27/07  
Tubize-Fin 56.270 56.270 58.000 56.270 -2.16% 8.94K 27/07  

Top Gainers

Name Last Chg. Chg. %
Mdxhealth 4.799 -0.001 -0.02%
UCB 69.50 -1.07 -1.52%
Tigenix NV 0.8080 -0.0130 -1.58%
Tubize-Fin 56.270 -1.240 -2.16%
Galapagos 49.880 -1.520 -2.96%

Top Losers

Name Last Chg. Chg. %
Celyad 51.51 -2.43 -4.51%
Thrombogenics 5.270 -0.200 -3.66%
Ablynx NV 13.500 -0.500 -3.57%
Galapagos 49.880 -1.520 -2.96%
Tubize-Fin 56.270 -1.240 -2.16%
Powered By

Follow Top Signal Providers

Account Nickname Net Profit P/L % Win % Weeks
SignalKING $35,362.08 436.94% 46.90% 246 Follow
SignalMAX $39,328.40 271.80% 69.18% 99 Follow
SignalWave $3,914.96 259.20% 93.68% 41 Follow
SignalAlpha $6,184.06 253.45% 68.68% 61 Follow
SignalPower $5,638.13 201.47% 70.79% 39 Follow

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Add Chart to Comment
BEL Pharmaceuticals & Biotechnology
 
 
 
Are you sure you want to delete this chart?
 
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
 
Are you sure you want to delete this chart?
 
 
 

Successfully Reported

Thank you. This comment has been flagged for a moderator.
_touchLoadingMsg
 
 
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.